Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014:2014:231236.
doi: 10.1155/2014/231236. Epub 2014 May 21.

The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients

Affiliations
Clinical Trial

The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients

Arezou Sayad et al. Biomed Res Int. 2014.

Abstract

The Hodgkin's lymphoma disease (HD) is a common malignant neoplasm with germinal centre B-cell origin. It has been suggested that the HLA class I and class II regions have susceptibility effects on HD. In different ethnic groups, different HLA class I and class II alleles affect HD. As a result, there is no consensus which of the different HLA alleles confers susceptibility to HD. In this study, we aimed to ascertain the role of HLA class I and class II alleles in association with Hodgkin's lymphoma in Iranian patients. We performed a case-control genotyping study in 85 Iranian HD patients which were selected from the Bone Marrow Transplantation Department of Taleghani Hospital and 150 controls using the SSP-PCR. Our results demonstrated that the HLA-A*68, HLA-B*51, and HLA-DRB1*15 alleles were significantly more frequent in HD patients in comparison to controls (P = 0.026; OR = 6.188, P = 0.00008; OR = 2.86, P = 0.00006; OR = 5.315, resp.) and they have significant susceptibility effects on HD in Iranian population. There are reports of other populations with regard to consistency and inconsistency to our results. Further studies with large sample size or the meta-analysis are needed to explain the exact associations of HLA gene with HD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hodgkin T. On some morbid experiences of the absorbent glands and spleen. Medico-Chirurgical Transactions. 1832;17:69–97. - PMC - PubMed
    1. Horning SJ. Hodgkin lymphoma. In: Lichtman MA, Beutler E, Kipps TJ, editors. Williams Hematology. 7th edition. New York, NY, USA: McGraw-Hill; 2006. pp. 1461–1482.
    1. Depil S, Moralès O, Auriault C. Hodgkin’s disease and Epstein-Barr virus. Annales de Biologie Clinique. 2004;62(6):639–648. - PubMed
    1. Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993;364(6432):33–39. - PubMed
    1. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994;76(2):287–299. - PubMed

Publication types